Product Information

AMLODIPINE-ATORVAST 10-80 MG is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $1.6441 per EA under NDC 62332076530. Its NADAC has been published 57 times since Jul 23, 2025.

FDA first approved this application on May 22, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-ATORVAST 10-80 MG

Amlodipine and Atorvastatin
$1.6441per EA

Strength

10; 80 mg/1; mg/1

NDC

62332076530

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA217279

FDA Approved

5/22/2025

TE Code

AB

On Market Since

5/23/2025

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for AMLODIPINE-ATORVAST 10-80 MG has been published 57 times since Jul 23, 2025, and over the history we have for it it has declined 18.4%. The table below summarizes its recorded NADAC range and movement.

Current price$1.6441 per EA
All-time high$2.1966 (Dec 10, 2025)
All-time low$1.6441 (Aug 19, 2026)
52-week high$2.1966
52-week low$1.6441
Median price$2.0137
Average price$1.9335
Largest weekly change-6.1% (Feb 18, 2026)
Weeks tracked57
Tracking sinceJul 23, 2025

Price History

1W

-1.9%

1M

-1.9%

3M

-0.8%

6M

-13.9%

1Y

-21.3%

3Y

N/A

5Y

N/A

All

-18.4%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-ATORVAST 10-80 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 10-80 MG, manufactured by Alembic Pharmaceuticals Inc., is $1.6441 per EA (NDC 62332076530), effective Aug 19, 2026.

How has the price of AMLODIPINE-ATORVAST 10-80 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 10-80 MG has declined 18.4%. It has been tracked across 57 weekly CMS publications since Jul 23, 2025.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 10-80 MG?

Since Jul 23, 2025, the NADAC for AMLODIPINE-ATORVAST 10-80 MG has ranged from a low of $1.6441 (Aug 19, 2026) to a high of $2.1966 (Dec 10, 2025), with a median of $2.0137 per EA.

Are there cheaper alternatives to AMLODIPINE-ATORVAST 10-80 MG?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-ATORVAST 10-80 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-ATORVAST 10-80 MG?

AMLODIPINE-ATORVAST 10-80 MG (NDC 62332076530) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.